318 results on '"Calabrese, Cecilia"'
Search Results
2. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
3. Impact of biologics on lung hyperinflation in patients with severe asthma
4. Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study
5. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus
6. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study
7. Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study
8. Alpha-1 Antitrypsin PI M Heterozygotes with Rare Variants: Do They Need a Clinical and Functional Follow-Up?
9. Severe asthma: One disease and multiple definitions
10. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
11. Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy.
12. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
13. Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission
14. Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study
15. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19
16. Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
17. Staphylococcus Aureus in chronic airway diseases: An overview
18. Association between exhaled nitric oxide and nasal polyposis in severe asthma
19. Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study
20. Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
21. Psychological Factors Influencing Adherence to NIV in Neuromuscular Patients Dependent on Non Invasive Mechanical Ventilation: Preliminary Results
22. Effects on Right Ventricular Function One Year after COVID-19-Related Pulmonary Embolism
23. Evaluation of Allergic Diseases, Symptom Control, and Relation to Infections in a Group of Italian Elite Mountain Bikers
24. Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report
25. Aerosol delivery through high-flow nasal therapy: Technical issues and clinical benefits
26. Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma
27. Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study
28. Evolution of the Clinical Profile and Outcomes of Unvaccinated Patients Affected by Critical COVID-19 Pneumonia from the Pre-Vaccination to the Post-Vaccination Waves in Italy
29. Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13
30. S. aureus and IgE-mediated diseases: pilot or copilot? A narrative review
31. Negative-Pressure Ventilation in Neuromuscular Diseases in the Acute Setting
32. Novel Biological Therapies for Severe Asthma Endotypes
33. Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism
34. Severe asthma: One disease and multiple definitions
35. Real-Life Effectiveness of Mepolizumab on Forced Expiratory Flow between 25% and 75% of Forced Vital Capacity in Patients with Severe Eosinophilic Asthma
36. Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis
37. Effectiveness of corticosteroids on HRCT features of COVID 19 pneumonia
38. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism
39. Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis
40. Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma
41. sj-docx-1-tar-10.1177_17534666211042533 – Supplemental material for Effectiveness of corticosteroids on chest high-resolution computed tomography features of COVID-19 pneumonia
42. sj-pdf-5-tar-10.1177_17534666211009398 – Supplemental material for Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
43. sj-docx-2-tar-10.1177_17534666211042533 – Supplemental material for Effectiveness of corticosteroids on chest high-resolution computed tomography features of COVID-19 pneumonia
44. sj-pdf-2-tar-10.1177_17534666211009398 – Supplemental material for Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
45. sj-pdf-4-tar-10.1177_17534666211009398 – Supplemental material for Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
46. sj-docx-3-tar-10.1177_17534666211042533 – Supplemental material for Effectiveness of corticosteroids on chest high-resolution computed tomography features of COVID-19 pneumonia
47. sj-pdf-3-tar-10.1177_17534666211009398 – Supplemental material for Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
48. sj-pdf-1-tar-10.1177_17534666211009398 – Supplemental material for Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
49. Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis
50. Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.